Previous Close | 2.4800 |
Open | 2.5000 |
Bid | 2.7400 x 100 |
Ask | 2.8400 x 100 |
Day's Range | 2.4400 - 2.8099 |
52 Week Range | 1.2350 - 10.2000 |
Volume | |
Avg. Volume | 243,065 |
Market Cap | 71.168M |
Beta (5Y Monthly) | 0.59 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for LPTX
Leap Therapeutics (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
In the classic tune by Kenny Rogers, ‘The Gambler,’ he sang, ‘Every hand’s a winner and every hand’s a loser…’ These words hold valuable wisdom that should resonate with every investor. Regardless of your chosen investment strategy, achieving success in the stock market ultimately hinges on mastering the art of balancing risk and reward. Few segments of the stock market offer a higher potential return for the risk involved than the penny stocks, those equities priced at $5 or less. These are sto
In this article, we will take a look at the 10 most promising penny stocks according to analysts. To see more such companies, go directly to 5 Most Promising Penny Stocks According to Analysts. Innovation is what drives human societies forward. Major companies of today were once small companies working on innovative and disruptive ideas. […]